The following is a summary of “Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

The following is a summary of “Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe ...

Summary. Exacerbations of COPD are common and can be detrimental to both patient health and health care costs. Corticosteroids are recommended by consensus guidelines for patients during ...

AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

Emphysema is a chronic lung condition that affects millions of people worldwide and can make everyday activities such as ...

Episodes of COPD exacerbation are also common in severe COPD. This is the most severe stage of COPD. Your FEV1 is less than 30% of normal predicted values or less than 50% with chronic respiratory ...

Researchers used computer modeling to predict which components of cigarette smoke might be recognized by antigen-presenting molecule MR1.

Verona Pharma stock hit a record high Thursday on continued enthusiasm for its newly launched COPD treatment, Ohtuvayre.

Cases of respiratory illnesses are increasing nationally and here in Brazos Valley. Local providers say the number of COVID, ...